Gómez-Jeria J S
Farmaco Sci. 1985 May;40(5):299-302.
The use in QSAR studies of parameters measuring the ability of an unlabeled molecule to compete for the binding site with a radioligand is examined. It is shown that in order to employ them within a recently developed formal model it is previously necessary to carry out a linear transformation. This necessarily demands the adoption by investigators of a standard measuring procedure.
本文考察了在定量构效关系(QSAR)研究中使用未标记分子与放射性配体竞争结合位点能力的参数的情况。结果表明,为了在最近开发的形式模型中使用这些参数,事先必须进行线性变换。这必然要求研究人员采用标准的测量程序。